Top Markets
#1 Official Trump Official Trump +42.55%
#2 Melania Meme Melania Meme +23.83%
#3 EXOD EXOD +18.93%
#4 Movement Movement +17.86%
#5 Mubarak Mubarak +17.15%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.62%
#7 POL (ex-MATIC) POL (ex-MATIC) +15.51%
#8 Wrapped POL Wrapped POL +15.32%
#9 Unit Pump Unit Pump +10.71%
#10 Pump.fun Pump.fun +10.71%
Coin of the day
Official Trump Official Trump
설정
언어
한국어
통화
USD
테마
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
주식 순위 #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
주가
$3.78
마지막 동기화: 2026-08-21
시가총액
$71.20M
변동 (1일)
2.24%
변동 (1년)
-43.37%
국가
FR
거래 MaaT Pharma S.A. (MAAT)

카테고리

Healthcare
MaaT Pharma S.A. (MAAT)의 배당 수익률 기록
MaaT Pharma S.A. (주식 심볼: MAAT)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
MaaT Pharma S.A. (MAAT)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)
회사 배당 수익률 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH